The Best Marijuana and Precision Medicine Stocks to Buy Might Not Be the Companies You Think
The marijuana market may be on its way to being worth $25 billion in 2021, and advances in DNA research could lead to next-generation precision medicine worth billions of dollars in annual sales. Yet, picking the winners and losers in these markets is a gamble.
Legislation could derail marijuana's momentum, and over 90% of medicines that enter clinical trials have historically ended up in laboratory dustbins, not on pharmacy shelves.
A better investment option might be to focus on Scotts Miracle-Gro (NYSE: SMG) and Illumina (NASDAQ: ILMN); two companies that supply the "picks and shovels" needed by companies that are targeting these market opportunities.
Source: Fool.com
Illumina Inc. Aktie
116,24 €
1,93 %
Die Community bevorzugt klar Illumina Inc. mit vielen Buy- und nur wenigen Sell-Einschätzungen.
Das Community-Kursziel von 160 € für Illumina Inc. deutet auf eine deutliche Steigerung um mehr als 20% gegenüber dem aktuellen Kurs von 116.24 € hin.
